Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | HTT | P42858 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | STAT3 | P40763 | 1/20 | 0.57 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.56 |
| ▸ | KDM6B | O15054 | 1/20 | 0.56 |
| ▸ | KDM5A | P29375 | 1/20 | 0.56 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.56 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.56 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.56 |
| ▸ | KDM3A | Q9Y4C1 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11651425 | 0.88 | LMNA (0.62) | KDM4ELMNAGAAALDH1A1MAPT | |
| SCHEMBL6101644 | 0.86 | SMN1; SMN2 (0.64) | KDM4ESMN1; SMN2HTTKMT2ALMNA | |
| SCHEMBL6099398 | 0.85 | KMT2A (0.64) | SMN1; SMN2HTTKMT2ALMNASTAT3 | |
| SCHEMBL6098990 | 0.84 | SMN1; SMN2 (0.60) | KDM4ESMN1; SMN2HTTKMT2ALMNA | |
| SCHEMBL6098671 | 0.84 | SMN1; SMN2 (0.57) | KDM4ESMN1; SMN2HTTKMT2ALMNA | |
| SCHEMBL6102149 | 0.83 | ANO1 (0.66) | SMN1; SMN2HTTKMT2ALMNASTAT3 | |
| SCHEMBL6101360 | 0.83 | MAPT (0.56) | SMN1; SMN2HTTKMT2ALMNASTAT3 | |
| SCHEMBL6101354 | 0.83 | MAPT (0.56) | SMN1; SMN2HTTKMT2ALMNASTAT3 | |
| SCHEMBL25769880 | 0.82 | NLRP3 (0.61) | SMN1; SMN2HTTKMT2ALMNASTAT3 | |
| SCHEMBL6111172 | 0.81 | SMN1; SMN2 (0.57) | SMN1; SMN2HTTKMT2ALMNASTAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1282640-C | N-arylphenylacetamide derivatives and medicinal compositions containing same | DAINIPPON PHARMACEUTICAL CO (JP) | 2006-11-01 | — | — | CN | disclosed |
| US-7084176-B2 | N-arylphenylacetamide derivatives and medicinal compositions containing the same | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 2006-08-01 | — | — | US | disclosed |
| US-20040248983-A1 | N-arylphenylacetamide derivatives and medicinal compositions containing the same | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 2004-12-09 | — | — | US | disclosed |
| CN-1529692-A | N-arylphenylacetamide derivatives and medicinal compositions containing same | 大日本制药株式会社 | 2004-09-15 | — | — | CN | disclosed |
| EP-1403235-A1 | N-ARYLPHENYLACETAMIDE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME | Dainippon Pharmaceutical Co., Ltd. (JP) | 2004-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040248983-A1 | N-arylphenylacetamide derivatives and medicinal compositions containing the same | HRH2, CCR8, CYP2C8 | KDM4E 3333/4885SMN1; SMN2 2474/4885HTT 1276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.